Search Results - "WANGHAI ZHANG"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Human Carboxylesterase 2 Is Commonly Expressed in Tumor Tissue and Is Correlated with Activation of Irinotecan by GUANG XU, WANGHAI ZHANG, MA, Margaret K, MCLEOD, Howard L

    Published in Clinical cancer research (01-08-2002)
    “…The prodrug irinotecan is an active agent for the treatment of advanced colorectal cancer and a number of other solid tumors. Irinotecan is converted in vivo…”
    Get full text
    Journal Article
  2. 2

    Pharmacogenomic profiling of the PI3K/PTEN-AKT-mTOR pathway in common human tumors by Xu, Guang, Zhang, Wanghai, Bertram, Paula, Zheng, Xiao Feng, McLeod, Howard

    Published in International journal of oncology (01-04-2004)
    “…The protein synthetic machinery is activated by a variety of genetic alterations during tumor progression and represents an attractive target for cancer…”
    Get more information
    Journal Article
  3. 3

    Therapeutic Synergy Between Irinotecan and 5-Fluorouracil against Human Tumor Xenografts by Azrak, Rami G, Cao, Shousong, Slocum, Harry K, Tóth, Károly, Durrani, Farukh A, Yin, Ming-biao, Pendyala, Lakshmi, Zhang, Wanghai, McLeod, Howard L, Rustum, Youcef M

    Published in Clinical cancer research (01-02-2004)
    “…Purpose: Although the combination of irinotecan and 5-Fluorouracil is clinically active, it is associated with significant toxicity and resistance. Studies…”
    Get full text
    Journal Article
  4. 4

    MAGED2 : A novel p53-dissociator by PAPAGEORGIO, Chris, BRACHMANN, Rainer, JUE ZENG, CULVERHOUSE, Robert, WANGHAI ZHANG, MCLEOD, Howard

    Published in International journal of oncology (01-11-2007)
    “…The tumor suppressor protein p53 is a transcription factor that is frequently mutated in human cancers. In response to DNA damage, unmutated or wild-type (wt)…”
    Get full text
    Journal Article
  5. 5

    Copy-number analysis of topoisomerase and thymidylate synthase genes in frozen and FFPE DNAs of colorectal cancers by Yu, Jinsheng, Miller, Ryan, Zhang, Wanghai, Sharma, Mala, Holtschlag, Vicky, Watson, Mark A, McLeod, Howard L

    Published in Pharmacogenomics (01-10-2008)
    “…Archived formalin-fixed, paraffin-embedded specimens represent an important resource for pharmacogenomic analysis in retrospective clinical studies but the…”
    Get more information
    Journal Article
  6. 6

    DNA Repair Pathway Profiling and Microsatellite Instability in Colorectal Cancer by Yu, Jinsheng, Mallon, Mary A, Zhang, Wanghai, Freimuth, Robert R, Marsh, Sharon, Watson, Mark A, Goodfellow, Paul J, McLeod, Howard L

    Published in Clinical cancer research (01-09-2006)
    “…Background: The ability to maintain DNA integrity is a critical cellular function. DNA repair is conducted by distinct pathways of genes, many of which are…”
    Get full text
    Journal Article
  7. 7

    Differential expression of the AP-1 transcription factor family members in human colorectal epithelial and neuroendocrine neoplasms by WANGHAI ZHANG, HART, John, MCLEOD, Howard L, WANG, Hanlin L

    Published in American journal of clinical pathology (01-07-2005)
    “…We immunohistochemically examined 75 human colorectal neoplasms (adenoma, 27; adenocarcinoma, 24; neuroendocrine carcinoma, 24) for the expression of activator…”
    Get full text
    Journal Article
  8. 8

    A mouse model for developing treatment for secondary liver tumors by Cai, Shi-Rong, Garbow, Joel R, Culverhouse, Robert, Church, Robert D, Zhang, Wanghai, Shannon, William D, McLeod, Howard L

    Published in International journal of oncology (01-07-2005)
    “…Metastatic colorectal cancer is the second most common cause of cancer mortality. The liver is a common site of metastasis and only a minority of patients with…”
    Get more information
    Journal Article
  9. 9

    Altered Expression of TFF-1 and CES-2 in Barrett's Esophagus and Associated Adenocarcinomas by Fox, Charles A., Sapinoso, Lisa M., Zhang, Hong, Zhang, Wanghai, McLeod, Howard L., Petroni, Gina R., Mullick, Tarun, Moskaluk, Christopher A., Frierson, Henry F., Hampton, Garret M., Powell, Steven M.

    Published in Neoplasia (New York, N.Y.) (01-04-2005)
    “…Identification of biomarkers to recognize individuals with Barrett's esophagus (BE) predisposed to develop malignancy is currently a pressing issue. We…”
    Get full text
    Journal Article
  10. 10
  11. 11

    In Situ Telomeric Repeat Amplification Protocol (TRAP) Detecting Telomerase Activity in Human Hepatocellular Carcinoma by Lu, Jian-Ping, Zhu, Shineng, Song, Baoping, Mao, Jianqun, Lu, Shilun, Su, Yinhao, Zhang, Wanghai

    Published in ACTA HISTOCHEMICA ET CYTOCHEMICA (01-01-1999)
    “…In situ telomeric repeat amplification protocol (TRAP) assay was used to show the telomerase activity on the cryostat section of hepatocellular carcinoma (HCC)…”
    Get full text
    Journal Article
  12. 12

    Image-based evaluation of the molecular events underlying HC11 mammary epithelial cell differentiation by Shan, Liang, Zhang, Renshu, Zhang, Wanghai, Lee, Edward, Sridhar, Rajagopalan, Snyderwine, Elizabeth G., Wang, Paul C.

    Published in Analytical biochemistry (15-11-2008)
    “…We have developed an image-based technique for signal pathway analysis, target validation, and compound screening related to mammary epithelial cell…”
    Get full text
    Journal Article
  13. 13

    Comprehensive evaluation of carboxylesterase-2 expression in normal human tissues using tissue array analysis by Zhang, Wanghai, Xu, Guang, McLeod, Howard L

    “…Carboxylesterases play an important role in the hydrolytic biotransformation of a number of structurally diverse endogenous compounds and medications. Several…”
    Get full text
    Journal Article
  14. 14

    Analysis of variation in mouse TPMT genotype, expression and activity by WATTERS, James W, WANGHAI ZHANG, MEUCCI, Melissa A, WEIYING HOU, MA, Margaret K, MCLEOD, Howard L

    Published in Pharmacogenetics (London) (01-04-2004)
    “…Although the mouse has great potential for pharmacogenomic discovery, little is known about variation in drug response or genetic variation in…”
    Get full text
    Journal Article
  15. 15

    Altered Expression of TFF-1 and CES-2 in Barrett's Esophagus and Associated Adenocarcinomas1 by Fox, Charles A, Sapinoso, Lisa M, Zhang, Hong, Zhang, Wanghai, McLeod, Howard L, Petroni, Gina R, Mullick, Tarun, Moskaluk, Christopher A, Frierson, Henry F, Hampton, Garret M, Powell, Steven M

    Published in Neoplasia (New York, N.Y.) (01-04-2005)
    “…Identification of biomarkers to recognize individuals with Barrett's esophagus (BE) predisposed to develop malignancy is currently a pressing issue. We…”
    Get full text
    Journal Article